Literature DB >> 28242012

National In-Hospital Outcomes of Pregnancy in Women With Single Ventricle Congenital Heart Disease.

R Thomas Collins1, Di Chang2, Adam Sandlin3, Anthony Goudie4, James M Robbins4.   

Abstract

Most patients with single ventricle (SV) congenital heart disease are expected to survive to adulthood. Women with SV are often counseled against pregnancy; however, data on pregnancies in these women are lacking. We sought to evaluate in-hospital outcomes of pregnancy in women with SV. We used nationally representative data from the 1998 to 2012 National Inpatient Sample to identify women ≥18 years of age admitted to the hospital with International Classification of Diseases-9th Revision codes for an intrauterine pregnancy and a diagnosis of hypoplastic left heart syndrome, tricuspid atresia, or common ventricle. A matched comparison group without a diagnosis of congenital heart disease or pulmonary hypertension was identified from the database. National estimates of hospitalizations were calculated. Length of stay, hospital charges, and complications were analyzed and compared between groups. Charge data were adjusted to 2012 dollars. There were 282 admissions of pregnant women with SV (69% with deliveries) and 1,405 admissions in the control group (88% with deliveries). Vaginal delivery was more common in SV (74% vs 71%, p <0.001). Length of stay (4.1 ± 0.91 vs 2.8 ± 0.18 days, p <0.001) and charges ($30,787 ± 8,109 vs $15,536 ± 1,006, p <0.0001) were higher in the SV group. Complications occurred in most SV admissions and were more common in the SV group than in the control group. No deaths occurred. Cardiovascular complications occurred in 25% of pregnancy-related hospitalizations, although in-hospital pregnancy-related death is rare. Vaginal delivery is common in these patients. These data suggest that pregnancy and vaginal delivery can be tolerated in women with SV, although the risk for a cardiovascular event is significantly higher than in the general population.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28242012      PMCID: PMC9220776          DOI: 10.1016/j.amjcard.2016.12.015

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   3.133


  21 in total

Review 1.  Risks of contraception and pregnancy in heart disease.

Authors:  Sara Thorne; Anne MacGregor; Catherine Nelson-Piercy
Journal:  Heart       Date:  2006-10       Impact factor: 5.994

2.  Maternal and fetal outcomes of pregnancy with Fontan circulation: A multicentric observational study.

Authors:  Marielle Gouton; Jacky Nizard; Mehul Patel; François Sassolas; Maria Jimenez; Jelena Radojevic; Amel Mathiron; Pascal Amedro; Elise Barre; Fabien Labombarda; Guy Vaksmann; Alain Chantepie; Laurianne Le Gloan; Magalie Ladouceur
Journal:  Int J Cardiol       Date:  2015-03-23       Impact factor: 4.164

3.  Pregnancy outcomes after the Fontan repair.

Authors:  M M Canobbio; D D Mair; M van der Velde; B J Koos
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

4.  Surgical repair of tricuspid atresia.

Authors:  F Fontan; E Baudet
Journal:  Thorax       Date:  1971-05       Impact factor: 9.139

5.  Health care resource utilization in adults with congenital heart disease.

Authors:  Andrew S Mackie; Louise Pilote; Raluca Ionescu-Ittu; Elham Rahme; Ariane J Marelli
Journal:  Am J Cardiol       Date:  2007-01-31       Impact factor: 2.778

6.  Maternal cardiovascular events during childbirth among women with congenital heart disease.

Authors:  Alexander R Opotowsky; Omar K Siddiqi; Benjamin D'Souza; Gary D Webb; Susan M Fernandes; Michael J Landzberg
Journal:  Heart       Date:  2011-10-11       Impact factor: 5.994

Review 7.  Outcome of pregnancy in women with congenital heart disease: a literature review.

Authors:  Willem Drenthen; Petronella G Pieper; Jolien W Roos-Hesselink; Willem A van Lottum; Adriaan A Voors; Barbara J M Mulder; Arie P J van Dijk; Hubert W Vliegen; Sing C Yap; Philip Moons; Tjark Ebels; Dirk J van Veldhuisen
Journal:  J Am Coll Cardiol       Date:  2007-06-04       Impact factor: 24.094

8.  Hypoplastic left heart syndrome: experience with palliative surgery.

Authors:  W I Norwood; J K Kirklin; S P Sanders
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

9.  Contraception Practices and Pregnancy Outcome in Patients after Fontan Operation.

Authors:  Kavitha N Pundi; Krishna Pundi; Jonathan N Johnson; Joseph A Dearani; Crystal R Bonnichsen; Sabrina D Phillips; Mary C Canobbio; David J Driscoll; Frank Cetta
Journal:  Congenit Heart Dis       Date:  2015-08-04       Impact factor: 2.007

Review 10.  The incidence of congenital heart disease.

Authors:  Julien I E Hoffman; Samuel Kaplan
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

View more
  4 in total

Review 1.  Pregnancy in a woman with a Fontan circulation: A review.

Authors:  Emily Moroney; Elske Posma; Alicia Dennis; Yves d'Udekem; Rachael Cordina; Dominica Zentner
Journal:  Obstet Med       Date:  2017-11-22

2.  Four successful pregnancies in a patient with Fontan palliation and congenital heart disease: a case report.

Authors:  Khalid S Al Najashi; Syed Mehdi; Shazia Mohsin; Merna Atiyah; Hafez A Abdullah; Jassim Abdulhameed; Ahmed M Al Zahrani
Journal:  J Cardiothorac Surg       Date:  2017-11-28       Impact factor: 1.637

3.  Length of hospital stay after delivery among Danish women with congenital heart disease: a register-based cohort study.

Authors:  Anne Marie Kirkegaard; Maria Breckling; Dorte Guldbrand Nielsen; Janne S Tolstrup; Søren Paaske Johnsen; Annette Kjær Ersbøll; Stine Kloster
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-07       Impact factor: 3.007

4.  Temporal Trends in Pregnancy-Associated Stroke and Its Outcomes Among Women With Hypertensive Disorders of Pregnancy.

Authors:  Pensée Wu; Kelvin P Jordan; Carolyn A Chew-Graham; Thais Coutinho; Gina P Lundberg; Ki E Park; Lucy C Chappell; Phyo K Myint; Angela H E M Maas; Mamas A Mamas
Journal:  J Am Heart Assoc       Date:  2020-07-29       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.